Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro

Injury. 2006 Sep:37 Suppl 3:S25-32. doi: 10.1016/j.injury.2006.08.021.

Abstract

Hydroxyapatite (HA) has been widely used as a bone graft substitute. In this study, we investigated whether the addition of osteogenic protein-1 (OP-1) further enhanced the weak osteoinductive properties of hydroxyapatite when loaded with human mesenchymal stem cells (h-MSCs). Over a 14 day period, cell proliferation in both groups was assessed qualitatively using SEM and quantitatively using alamar blue assay. Cell differentiation was also evaluated by measurement of ALP activity, which was expressed against total DNA. HA/MSC loaded with OP-1 demonstrated a statistically significant increase (p<0.001) in cell proliferation at all time points in comparison to unloaded samples. ALP activity per DNA was also significantly enhanced (p<0.001) in loaded samples when compared to unloaded controls. SEM demonstrated increased cellular attachment and proliferation into HA pores at all time points in the loaded samples. Our study suggests that the osteoinductive potential of HA can be improved in vitro by the combined incorporation of MSCs and OP-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biocompatible Materials / pharmacology*
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins / physiology*
  • Bone Regeneration / physiology*
  • Cell Differentiation
  • Cell Proliferation
  • Durapatite / pharmacology*
  • Humans
  • Male
  • Mesenchymal Stem Cells*
  • Osteoblasts / physiology
  • Tissue Engineering / methods

Substances

  • BMP7 protein, human
  • Biocompatible Materials
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Durapatite